Infliximab (Indonesian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Infliximab" in Indonesian language version.
refsWebsite
Global rank
Indonesian rank
5th place
7th place
610th place
597th place
6,828th place
6,332nd place
doi.org
- Baert, Filip; Noman, Maja; Vermeire, Severine; Van Assche, Gert; D' Haens, Geert; Carbonez, An; Rutgeerts, Paul (2003-02-13). "Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease". New England Journal of Medicine (dalam bahasa Inggris). 348 (7): 601–608. doi:10.1056/NEJMoa020888. ISSN 0028-4793.
- Mauser, J; Hyams, J (1999-06). "Infliximab: A novel chimeric monoclonal antibody for the treatment of Crohn's disease". Clinical Therapeutics (dalam bahasa Inggris). 21 (6): 932–942. doi:10.1016/S0149-2918(99)80015-0.
- Guo, Yuan; Lu, Nonghua; Bai, Aiping (2013). "Clinical Use and Mechanisms of Infliximab Treatment on Inflammatory Bowel Disease: A Recent Update". BioMed Research International (dalam bahasa Inggris). 2013: 1–9. doi:10.1155/2013/581631. ISSN 2314-6133. PMC 3581271
. PMID 23484133. - Smolen, Josef S.; Emery, Paul (2011-05-25). "Infliximab: 12 years of experience". Arthritis Research & Therapy. 13 (1): S2. doi:10.1186/1478-6354-13-S1-S2. ISSN 1478-6354. PMC 3123963 . PMID 21624181.
elsevier.com
linkinghub.elsevier.com
- Mauser, J; Hyams, J (1999-06). "Infliximab: A novel chimeric monoclonal antibody for the treatment of Crohn's disease". Clinical Therapeutics (dalam bahasa Inggris). 21 (6): 932–942. doi:10.1016/S0149-2918(99)80015-0.
hindawi.com
- Guo, Yuan; Lu, Nonghua; Bai, Aiping (2013). "Clinical Use and Mechanisms of Infliximab Treatment on Inflammatory Bowel Disease: A Recent Update". BioMed Research International (dalam bahasa Inggris). 2013: 1–9. doi:10.1155/2013/581631. ISSN 2314-6133. PMC 3581271 . PMID 23484133.
nejm.org
- Baert, Filip; Noman, Maja; Vermeire, Severine; Van Assche, Gert; D' Haens, Geert; Carbonez, An; Rutgeerts, Paul (2003-02-13). "Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease". New England Journal of Medicine (dalam bahasa Inggris). 348 (7): 601–608. doi:10.1056/NEJMoa020888. ISSN 0028-4793.
nih.gov
ncbi.nlm.nih.gov
- Fatima, Rawish; Bittar, Khaled; Aziz, Muhammad (2024). Infliximab. Treasure Island (FL): StatPearls Publishing. PMID 29763197.
- Guo, Yuan; Lu, Nonghua; Bai, Aiping (2013). "Clinical Use and Mechanisms of Infliximab Treatment on Inflammatory Bowel Disease: A Recent Update". BioMed Research International (dalam bahasa Inggris). 2013: 1–9. doi:10.1155/2013/581631. ISSN 2314-6133. PMC 3581271 . PMID 23484133.
- Smolen, Josef S.; Emery, Paul (2011-05-25). "Infliximab: 12 years of experience". Arthritis Research & Therapy. 13 (1): S2. doi:10.1186/1478-6354-13-S1-S2. ISSN 1478-6354. PMC 3123963 . PMID 21624181.
worldcat.org
- Baert, Filip; Noman, Maja; Vermeire, Severine; Van Assche, Gert; D' Haens, Geert; Carbonez, An; Rutgeerts, Paul (2003-02-13). "Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease". New England Journal of Medicine (dalam bahasa Inggris). 348 (7): 601–608. doi:10.1056/NEJMoa020888. ISSN 0028-4793.
- Wu, Jashin J.; Feldman, Steven R.; Lebwohl, Mark, ed. (2017). Therapy for severe psoriasis. Philadelphia: Elsevier. hlm. 97. ISBN 978-0-323-44797-3. OCLC 953844083.
- Guo, Yuan; Lu, Nonghua; Bai, Aiping (2013). "Clinical Use and Mechanisms of Infliximab Treatment on Inflammatory Bowel Disease: A Recent Update". BioMed Research International (dalam bahasa Inggris). 2013: 1–9. doi:10.1155/2013/581631. ISSN 2314-6133. PMC 3581271 . PMID 23484133.
- Smolen, Josef S.; Emery, Paul (2011-05-25). "Infliximab: 12 years of experience". Arthritis Research & Therapy. 13 (1): S2. doi:10.1186/1478-6354-13-S1-S2. ISSN 1478-6354. PMC 3123963 . PMID 21624181.